Molecular alterations and therapeutic targets in pancreatic neuroendocrine tumors
Human pancreatic neuroendocrine tumors (PanNETs) are a rare, deadly tumor type that is sporadic or arises in the background of a hereditary syndrome. A critical genetic event in sporadic tumors is inactivation of the gene menin 1 (MEN1) on chromosome 11, and indeed, PanNETs occur in patients with th...
Main Authors: | Yarui Ma, Xiaoyue Wang, Hong Zhao, Yuchen Jiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2023-09-01
|
Series: | Journal of Pancreatology |
Online Access: | http://journals.lww.com/10.1097/JP9.0000000000000125 |
Similar Items
-
Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets
by: Chandra K. Maharjan, et al.
Published: (2021-10-01) -
Molecular Genetic Studies of Pancreatic Neuroendocrine Tumors: New Therapeutic Approaches
by: Stevenson, M, et al.
Published: (2018) -
Molecular Pathogenesis of Pancreatic Neuroendocrine Tumors
by: Robert Grützmann, et al.
Published: (2010-11-01) -
Targeting HDACs in Pancreatic Neuroendocrine Tumor Models
by: Rosa Lynn Schmitz, et al.
Published: (2021-06-01) -
Molecular biology of pancreatic neuroendocrine tumors: From mechanism to translation
by: Xiaofei Shen, et al.
Published: (2022-09-01)